Skip to main content
Premium Trial:

Request an Annual Quote

Chemicon to Distribute MorphoSys Antibodies

NEW YORK, Jan. 10 (GenomeWeb News) - Serologicals subsidiary Chemicon International and MorphoSys signed a three-year agreement to distribute MorphoSys's research antibodies through Chemicon's sales network, said today.

 

Chemicon will pay MorphoSys for antibody generation, optional additional fees, and royalties on all products.

 

Under the agreement, MorphoSys's Antibodies by Design unit will develop antibodies from its HuCAL GOLD antibody library against targets identified and supplied by Chemicon. Chemicon will market the HuCal-based research antibodies as stand-alone products or as components of reagent kits.

 

The companies anticipate 100 research antibody projects per year over the life of the alliance.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.